199 related articles for article (PubMed ID: 36892953)
1. Prognostic and clinicopathological significance of Systemic Immune-Inflammation Index in cancer patients receiving immune checkpoint inhibitors: a meta-analysis.
Wang Y; Ni Q
Ann Med; 2023 Dec; 55(1):808-819. PubMed ID: 36892953
[TBL] [Abstract][Full Text] [Related]
2. Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma.
Zheng J; Peng L; Zhang S; Liao H; Hao J; Wu S; Shen H
Front Immunol; 2023; 14():1275033. PubMed ID: 38053997
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis.
Tian BW; Yang YF; Yang CC; Yan LJ; Ding ZN; Liu H; Xue JS; Dong ZR; Chen ZQ; Hong JG; Wang DX; Han CL; Mao XC; Li T
Immunotherapy; 2022 Dec; 14(18):1481-1496. PubMed ID: 36537255
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of pretreatment systemic immune-inflammation index in patients with prostate cancer: a meta-analysis.
Zhang B; Xu T
World J Surg Oncol; 2023 Jan; 21(1):2. PubMed ID: 36600256
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis.
Fan Z; Shou L
Ther Adv Hematol; 2023; 14():20406207231208973. PubMed ID: 37954483
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
Zhang Y; Sun Y; Zhang Q
Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients.
Shui Y; Li M; Su J; Chen M; Gu X; Guo W
Aging (Albany NY); 2021 Aug; 13(16):20585-20597. PubMed ID: 34435973
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis.
Zeng Z; Xu S; Wang D; Qin G
Syst Rev; 2022 Nov; 11(1):247. PubMed ID: 36403072
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis.
Li M; Li Z; Wang Z; Yue C; Hu W; Lu H
Clin Exp Med; 2022 Nov; 22(4):637-646. PubMed ID: 35022918
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.
Jin M; Yuan S; Yuan Y; Yi L
Front Oncol; 2021; 11():735803. PubMed ID: 34950577
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pretreatment systemic immune-inflammation index in patients with endometrial cancer: a meta-analysis.
Ji P; He J
Biomark Med; 2024 Apr; ():. PubMed ID: 38623927
[No Abstract] [Full Text] [Related]
12. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.
Meng L; Yang Y; Hu X; Zhang R; Li X
J Transl Med; 2023 Feb; 21(1):79. PubMed ID: 36739407
[TBL] [Abstract][Full Text] [Related]
13. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis.
Li X; Gu L; Chen Y; Chong Y; Wang X; Guo P; He D
Ann Med; 2021 Dec; 53(1):1827-1838. PubMed ID: 34647517
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis.
Dong M; Shi Y; Yang J; Zhou Q; Lian Y; Wang D; Ma T; Zhang Y; Mi Y; Gu X; Fan R
Ther Adv Med Oncol; 2020; 12():1758835920937425. PubMed ID: 32699557
[TBL] [Abstract][Full Text] [Related]
15. Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta‑analysis.
Kou J; Huang J; Li J; Wu Z; Ni L
Clin Exp Med; 2023 Nov; 23(7):3895-3905. PubMed ID: 36966477
[TBL] [Abstract][Full Text] [Related]
16. Revealing the prognostic and clinicopathological significance of systemic immune-inflammation index in patients with different stage prostate cancer: A systematic review and meta-analysis.
Qi W; Zhou Y; Liu Z; Wang J; Lv G; Zhong M; Wang W; Li R; Chen S; Shi B; Zhu Y
Front Med (Lausanne); 2022; 9():1052943. PubMed ID: 36388917
[TBL] [Abstract][Full Text] [Related]
17. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
[TBL] [Abstract][Full Text] [Related]
18. Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy.
Ekinci F; Balcik OY; Demir B; Gursoy P; Ozveren A; Erdogan AP
J Coll Physicians Surg Pak; 2022 Aug; 32(8):996-1003. PubMed ID: 35932122
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis.
Qiu Y; Zhang Z; Chen Y
Front Oncol; 2021; 11():537140. PubMed ID: 33777726
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer.
Li J; Cao D; Huang Y; Xiong Q; Tan D; Liu L; Lin T; Wei Q
Front Immunol; 2022; 13():865643. PubMed ID: 35572533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
